Indapamide: Clinical Trials

12 trials of Indapamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 5 unknown, 1 recruiting, 1 suspended. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Completed 5, Unknown 5, Recruiting 1, Suspended 1

Follow Indapamide: new trials by email Literature Review of Indapamide trials Research Report on Indapamide

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism
Indapamide 1.5 MG SR, Placebo - Hypoparathyroidism Post-surgical
Phase 4RecruitingLars Rejnmark242025-08-012025-08-11
Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India
Amlodipine + Perindopril, Perindopril + Indapamide, Amlodipine + Indapamide - Primary Hypertension
Phase 4CompletedCentre for Chronic Disease Control, India19812022-08-302024-10-08
Effect of Genetic Polymorphisms of UGT on the PKs of Indapamide in Egyptians
Indapamide 1.5 MG SR - Pharmacogenomics
Phase 4UnknownAin Shams University382022-03-152022-03-24
The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure
Spironolactone, Indapamide - Hypertension
Phase 4UnknownShanghai Jiao Tong University School of Medicine2002020-09-232021-12-08
Coronavirus (COVID-19) ACEi/ARB Investigation
Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor - Hypertension, COVID-19
Phase 4SuspendedNational University of Ireland, Galway, Ireland24142020-04-302020-06-30
Once-daily Fixed Combination of Three Antihypertensive Drugs
perindopril, indapamide , amlodipine, Tripliam (perindopril, indapamide, amlodipine) - Arterial Hypertension
Phase 4UnknownUniversity of Roma La Sapienza1002016-04-012016-03-16
Low-dose Combination of Three Antihypertensive Drugs
Tripliam (perindopril, indapamide, amlodipine), Reaptan (perindopril, amlodipine) - Arterial Hypertension
Phase 4UnknownUniversity of Roma La Sapienza1002016-04-012016-03-17
Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria
Renin-angiotensin system blockers, non-renin angiotensin system blockers - Diabetes, Hypertensive Disease
Phase 4UnknownHospital Authority, Hong Kong14002011-11-012016-09-05
Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency
Indapamide, Hydrochlorothiazide - Hypertension, Renal Insufficiency
Phase 4CompletedWest China Hospital2402010-09-012014-06-24
A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM
Hydrochlorothiazide, Indapamide - Hypertension, Type 2 Diabetes Mellitus
Phase 4CompletedLaborMed Pharma S.A.562008-03-012011-06-15
IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs
Indapamide (T2), Perindopril (T1), Placebo of Perindopril (P1) - Hypertension
Phase 4CompletedHospices Civils de Lyon1392004-10-012025-12-19
Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy
Ambulatory blood pressure monitoring, Chronotherapy, timing of antihypertensive medication, ACEI (including spirapril, enalapril, quinapril, lisinopril) - Hypertension
Phase 4CompletedUniversity of Vigo33442000-03-012009-04-28

Conditions studied

Hypertension (9)  ·  COVID-19 (1)  ·  Cardiovascular Diseases (1)  ·  Coronavirus Infections (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Essential Hypertension (1)  ·  Hypercalciuria (1)  ·  Hypoparathyroidism (1)  ·  Renal Insufficiency (1)

Sponsors

University of Roma La Sapienza (2)  ·  Ain Shams University (1)  ·  Centre for Chronic Disease Control, India (1)  ·  Hospices Civils de Lyon (1)  ·  Hospital Authority, Hong Kong (1)  ·  LaborMed Pharma S.A. (1)  ·  Lars Rejnmark (1)  ·  National University of Ireland, Galway, Ireland (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  University of Vigo (1)  ·  West China Hospital (1)

Countries

China (3)  ·  Italy (2)  ·  Denmark (1)  ·  France (1)  ·  India (1)  ·  Ireland (1)  ·  Romania (1)  ·  Spain (1)

Top investigators

Carlo Gaudio, MD (2)  ·  Dorairaj Prabhakaran, DM Cardiology (1)  ·  Dragos Vinereanu, Professor, MD, PhD (1)  ·  John William McEvoy, MBBCh MHS (1)  ·  Nagwa A. Sabri, professor (1)  ·  Ramon C Hermida, PhD (1)  ·  Wai Sing, Daniel CHU, M.B.,B.S. (1)  ·  Xiao P Chen, master (1)

Results publications

PMID 19407805, PMID 21617110, PMID 21884956, PMID 24739801, PMID 26399404, PMID 27522394, PMID 40715816